Search clinical trials for: Placebo

Total 53560 results

Allergan

Terminated

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

Diabetes Mellitus | Gastroparesis

United States, Canada, Australia, Russian Federation, India, Thailand, Korea, Republic of, Singapore, Mexico, Israel, Poland, Belgium, Bulgaria, Malaysia, Philippines, Ukraine, South Africa, Austria, Brazil, United Kingdom, Arge... and more
Viela Bio

Terminated

Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection (ALI)

Acute Lung Injury

United States
Novartis Pharmaceuticals
Wellcome Trust

Completed

Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects

Malaria

Belgium
Hoffmann-La Roche

Completed

A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease (Scarlet Road)

Alzheimer's Disease

United States, Korea, Republic of, Argentina, Belgium, Brazil, Canada, Australia, United Kingdom, Germany, Portugal, Denmark, Finland, France, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, Turkey, Chile, Czechia and more
Regeneron Pharmaceuticals

Terminated

Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Adult Volunteers

Healthy Volunteer

United States
Kyowa Kirin Co., Ltd.

Completed

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia

Japan
Spectrum Pharmaceuticals, Inc

Completed

The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate

Benign Prostatic Hypertrophy

United States
Novartis Pharmaceuticals

Completed

Safety Study of LLF580 in Obese Volunteers

Obesity

United States
AnGes, Inc.

Completed

AMG0103 in Subjects With Chronic Discogenic Lumbar Back Pain

Degenerative Disc Disease

United States
Guerbet

Completed

Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy Volunteers

Pharmacokinetics

Japan
Eli Lilly and Company

Completed

A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis

Dermatitis, Atopic

United States, Puerto Rico
Novartis Pharmaceuticals

Completed

PD of VAY736 in Patients With Primary Sjögren's Syndrome (CVAY736X2201)

Primary Sjögren's Syndrome

Germany
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD)

Healthy

China
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)

Healthy

China
EmeraMed

Completed

Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA) (EMERA006)

Multiple System Atrophy | Progressive Supranuclear Palsy

Slovenia
Denovo Biopharma LLC

Terminated

A Study in Schizophrenic Patients

Schizophrenia

Japan, Taiwan, Korea, Republic of
ObsEva SA

Completed

Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF (IMPLANT4)

Infertility

Belgium, Canada, Czechia, Denmark, Estonia, Germany, Hungary, Poland, Russian Federation, Spain
KoBioLabs
Novotech (Australia) Pty Limited

Completed

A Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects

Atopic Dermatitis (AD)

Australia
Maastricht University Medical Center
BioActor B.V.

Completed

The Effect of Aronia Melanocarpa Extract on Cognitive Function

Cognitive Function

Netherlands
SIMR (Australia) Biotech Pty Ltd.
Syneos Health

Completed

The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers

Healthy Volunteers

Australia
Jiangsu HengRui Medicine Co., Ltd.

Enrolling by invitation

A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics of HRS4800 in Healthy Subjects

Pain

China
Materia Medica Holding

Completed

Clinical Trial of Safety and Efficacy of New Dosage Schedule for Dietressa Drug in Treatment of Obese Patients

Obesity

Russian Federation
Rhizen Pharmaceuticals SA

Completed

A Single and Multiple Ascending and Food Effect Study of RP7214, a DHODH Inhibitor in Healthy Adult Subjects

Healthy Volunteers

United States
Hoffmann-La Roche

Completed

A Single Ascending Dose Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Intravenously Administered RO7126209 in Healthy Participants

Alzheimers Disease

United States
AriBio Co., Ltd.

Completed

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

Mild to Moderate Alzheimer's Disease

United States
Eisai Co., Ltd.

Completed

A Study to Assess the Safety and Tolerability of E6742 in Japanese Healthy Adult Participants

Healthy Volunteers

Japan
AstraZeneca

Terminated

Safety and Tolerability Study of AZD4831 in Patients With Heart Failure. (SATELLITE)

Heart Failure

Denmark, Finland, Netherlands, United States, Sweden
Galmed Research and Development, Ltd.
Medical University of Graz; Tel-Aviv Sourasky Medical Center; Fondazione IRCCS... and other collaborators

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH (Aramchol_005)

Liver Diseases | Fatty Liver | Non-Alcoholic Steatohepatitis | Liver Fibroses

United States, Chile, Israel, Italy, France, Germany, Mexico, Georgia, Lithuania, Hong Kong, Romania
Allergan

Completed

12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine

Episodic Migraine

United States
University of California, San Diego
Amgen

Completed

Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

Postural Orthostatic Tachycardia Syndrome

United States
Chugai Pharmaceutical

Terminated

A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism

Hypoparathyroidism

United States, Canada, Hungary
Atox Bio Ltd

Completed

AB103 Peptide Antagonist in Healthy Volunteers

Healthy Volunteer Safety Study

United States
Biogen

Terminated

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's Disease

Parkinson's Disease

Japan
Jiangsu HengRui Medicine Co., Ltd.

Completed

The PK/PD Study of SHR2285 Tablets in Healthy Subjects

Thrombosis

China
Aptevo Therapeutics

Terminated

Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis

Psoriasis | Ulcerative Colitis

Australia
Lateral Pharma Pty Ltd

Completed

A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine

Acute Migraine

Australia
Viking Therapeutics, Inc.

Completed

Acute Hip Fracture Study in Patients 65 Years or Greater

Hip Fractures

Serbia, United States, Hungary, Romania
Revolo Biotherapeutics

Completed

Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers

Healthy Volunteer

United Kingdom
Daiichi Sankyo, Inc.

Completed

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis

Atopic Dermatitis

United States
Eli Lilly and Company

Terminated

A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis (ADmIRe)

Atopic Dermatitis

Spain, Puerto Rico, United States, Canada, Japan, Italy, Argentina, Austria, Czechia, France, Germany, Hungary, Mexico
Hanmi Pharmaceutical Company Limited

Completed

Study for Multiple Doses of HM15136 in Obese or Overweight Subjects With Comorbidities

Type2 Diabetes | Obese With Comorbidities | Overweight With Comorbidities

United States
PHARMENTERPRISES LLC

Completed

Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia

SARS-CoV-2 Infection | Fibrosis Lung

Russian Federation
Zeria Pharmaceutical

Completed

Exploratory Study of ZG-801 for the Treatment of Hyperkalemia

Hyperkalemia

Japan
Emergo Therapeutics, Inc.

Completed

Norketotifen for the Treatment of Uncomplicated Influenza-like Illness

Influenza -Like Illness

United States
Eisai Inc.
Biogen

Terminated

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

Alzheimer Disease | Dementia, Alzheimer Type

United States
Eli Lilly and Company

Completed

A Study of LY3361237 in Participants With Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic

United States
Sichuan Haisco Pharmaceutical Group Co., Ltd

Completed

Safety, Tolerability, and Pharmacokinetics of HSK21542 in Healthy Volunteers

Chronic Pain | Postoperative Pain

Australia
MedImmune LLC
National Institute of Allergy and Infectious Diseases (NIAID); Antibacterial... and other collaborators

Completed

Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects (EVADE)

Pseudomonas Aeruginosa

Spain, United States, Belgium, France, Hungary, United Kingdom, Israel, Austria, Portugal, Greece, Czechia, Turkey, Croatia, Ireland
Eli Lilly and Company

Completed

A Safety Study of LY3493269 in Healthy Participants

Healthy

Singapore
Novartis Pharmaceuticals

Completed

QVA Mechanistic Efficacy Study (Receptor Effects, Etc)

Chronic Obstructive Pulmonary Disease

United Kingdom

Search clinical trials for: Placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations